Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
format_facet:"Elektronische Ressource"
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Case+Reports%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Case+Reports%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Case+Reports%22&type=Subject
PubPharm (10)
1
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study : Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
4
Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study : Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
5
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
6
Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301 : Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
7
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
8
Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301 : Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
9
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
10
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
10
Aufsätze
10
E-Artikel
E-Ressourcen
Zeitschriftentitel
10
WHO International Clinical Trials Registry Plat...
Thema
10
610
10
Recruitment Status: Not yet recruiting
10
Study Type: Interventional
8
Medical Condition: Japanese encephalitis (JE) i...
2
Medical Condition: Genotropin®) is approved fo...
2
Phase: Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
2
2019
2
2014
4
2013
2
2012
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...